Physician profile
Rich Yang
NPI 1982054003
$6,573.02
in general payments reported to CMS, 2019-2025
15 companies · $1,617 in 2025
The $1,617 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,086 · 2020: $260 · 2021: $201 · 2022: $571 · 2023: $1,245 · 2024: $593 · 2025: $1,617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,224 · Travel and Lodging: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,223.96 |
| Travel and Lodging | $231.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,621.37 | 2021-2025 | Misight Contact Lens, Myday Contact Lens, Synergeyes Contact Lens |
| Alcon Vision LLC | $1,498.75 | 2019-2025 | Precision7, Precision 1, Dailies Total1 |
| Johnson & Johnson Vision Care, INC. | $1,076.27 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $955.85 | 2022-2025 | Infuse, Alden Scleral Zenlens, Xiidra |
| Visioneering Technologies, INC. | $330.87 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $311.54 | 2019-2021 | |
| Glaukos Corporation | $163.36 | 2022 | |
| Dompe US, INC. | $158.58 | 2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $122.33 | 2024-2025 | Xdemvy |
| Sight Sciences, INC. | $94.36 | 2019-2021 | |
| Abbvie INC. | $59.42 | 2022-2023 | Lumigan, Vuity |
| Shire North American Group INC | $51.21 | 2019 | |
| Thea Pharma INC. | $47.68 | 2023 | |
| Biotissue Holdings INC. | $42.63 | 2019 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rich Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.